Tofacitinib for the treatment of ulcerative colitis: up to 4.4 years of safety data from global clinical trials

被引：0
|
作者：
Sandborn, W. J. [1 ]
Panes, J. [2 ]
D'Haens, G. R. [3 ]
Sands, B. E. [4 ]
Su, C. [5 ]
Moscariello, M. [5 ]
Jones, T. V. [5 ]
Pedersen, R. D. [5 ]
Friedman, G. S. [5 ]
Lawendy, N. [5 ]
Chan, G. [5 ]
机构：
[1] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA
[2] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
[3] Acad Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands
[4] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
[5] Pfizer Inc, Collegeville, PA USA
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP023
引用
收藏
页码：S45 / S46
页数：3
相关论文
共 50 条
  • [31] Tofacitinib for the Treatment of Ulcerative Colitis: An Updated Analysis of Infection Rates in the Tofacitinib Ulcerative Colitis Clinical Program
    Winthrop, Kevin L.
    Loftus, Edward V., Jr.
    Baumgart, Daniel C.
    Hart, Ailsa
    Alharbi, Othman R.
    Salese, Leonardo
    Lawendy, Nervin
    Mundayat, Rajiv
    Su, Chinyu
    Reinisch, Walter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S323 - S323
  • [32] The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: updated results from the tofacitinib ulcerative colitis clinical programme
    Sands, B. E.
    Taub, P. R.
    Feagan, B. G.
    Armuzzi, A.
    Damiao, A. O.
    Lawendy, N.
    Solano, G.
    Kwok, K.
    Woolcott, J.
    Salese, L.
    Su, C.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S557 - S558
  • [33] THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS - UPDATED RESULTS FROM THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM
    Sands, Bruce E.
    Taub, Pam R.
    Feagan, Brian G.
    Armuzzi, Alessandro
    Damiao, Aderson O.
    Lawendy, Nervin
    Solano, Gaston
    Kwok, Kenneth
    Woolcott, John
    Salese, Leonardo
    Su, Chinyu
    GASTROENTEROLOGY, 2020, 158 (06) : S1190 - S1190
  • [34] THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE TOFACITINIB OCTAVE ULCERATIVE COLITIS CLINICAL PROGRAM
    Vermeire, Severine
    Armuzzi, Alessandro
    Kwok, Kenneth K.
    Lawendy, Nerrvin
    Woolcott, John
    Salese, Leonardo
    Su, Chinyu
    Hudesman, David
    GASTROENTEROLOGY, 2021, 160 (06) : S353 - S353
  • [35] Impact of Baseline Corticosteroid Therapy on Tofacitinib Induction Efficacy and Infection Risk in Patients With Ulcerative Colitis: Data From Global Clinical Trials
    Lichtenstein, Gary R.
    Cohen, Benjamin L.
    Salese, Leonardo
    Soonasra, Arif
    Modesto, Irene
    Wang, Wenjin
    Woodworth, Deborah A.
    Chan, Gary
    Quirk, Daniel
    Su, Chinyu
    Peyrin-Biroulet, Laurent
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S415 - S415
  • [36] Correlation of lipid levels with reduction in inflammation in patients with ulcerative colitis: Data from the tofacitinib OCTAVE clinical trials
    Feagan, B. G.
    Ha, C. Y.
    Taub, P. R.
    Quirk, D.
    Nduaka, C. I.
    Salese, L.
    Chan, G.
    Friedman, G. S.
    Wang, W.
    Su, C.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S453 - S454
  • [37] CORRELATION OF LIPID LEVELS WITH REDUCTION IN INFLAMMATION IN PATIENTS WITH ULCERATIVE COLITIS: DATA FROM THE TOFACITINIB OCTAVE CLINICAL TRIALS
    Feagan, Brian G.
    Ha, Christina
    Taub, Pam R.
    Quirk, Daniel
    Nduaka, Chudy I.
    Salese, Leonardo
    Chan, Gary
    Friedman, Gary S.
    Wang, Wenjin
    Su, Chinyu
    Reinisch, Walter
    GASTROENTEROLOGY, 2018, 154 (06) : S386 - S387
  • [38] Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis
    Sandborn, William J.
    Peyrin-Biroulet, Laurent
    Quirk, Daniel
    Wang, Wenjin
    Nduaka, Chudy, I
    Mukherjee, Arnab
    Su, Chinyu
    Sands, Bruce E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1821 - +
  • [39] Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program
    Sands, Bruce E.
    Long, Millie D.
    Reinisch, Walter
    Panes, Julian
    Loftus, Edward, V
    Nduaka, Chudy, I
    Soonasra, Arif
    Mundayat, Rajiv
    Lawendy, Nervin
    Chan, Gary
    Friedman, Gary S.
    Su, Chinyu
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (02) : 234 - 245
  • [40] Efficacy and Safety of Tofacitinib in Moderate and Severe Ulcerative Colitis in Real Clinical Practice: 3 Years of Observation
    Podolskaya, Daria
    Knyazev, Oleg
    Kagramanova, Anna
    Lishchinskaya, Albina
    Nanaeva, Bella
    Fadeeva, Nina
    Kulakov, Dmitriy
    Zvyaglova, Mariya
    Li, Irina
    Shkurko, Tatyana
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S7 - S7
12345